Data from advanced clinical studies of a new type of diabetes drug being developed by a unit of Johnson & Johnson showed it reduced a measure of blood sugar in patients with type 2 diabetes.
WSJ.com: US Business, Wall Street Journal: Business
Sun, 06/10/2012 - 4:33pm
Data from advanced clinical studies of a new type of diabetes drug being developed by a unit of Johnson & Johnson showed it reduced a measure of blood sugar in patients with type 2 diabetes.